Synthesis of benzothieno-annelated hydropyridine derivatives
41
CDCl3): d = 19.88, 20.46, 20.81, 31.98, 33.05, 34.68,
55.77, 58.53, 123.70, 126.73, 126.76, 128.61, 129.29,
130.52, 133.71, 139.94 ppm; MS (EI, 70 eV): m/z = 259
(M?), 244 (M?-CH3).
precipitate was isolated by filtration, washed with water,
dried, and recrystallized from 10:1 2-propanol–water.
5-Ethyl-3,4,5,6-tetrahydro-3,3,6-trimethyl[1]benzothie-
no[2,3-c]quinolin-1(2H)-one (11c, C20H23NOS)
6-Chloro-1,2,3,4-tetrahydro-1,3-dimethyl-2-phenyl[1]
benzothieno[2,3-c]pyridine hydrochloride
(9c, C19H19Cl2NS)
This compound was obtained from salt 4c in 78% yield as
white crystals. M.p.: 186–187 °C; 1H NMR (400 MHz,
CDCl3): d = 1.15 (3H, s, 3-CH3), 1.16 (3H, s, 3-CH3), 1.26
(3H, t, J = 7.1 Hz, CH3CH2), 1.39 (3H, d, J = 6.3 Hz,
6-CH3), 2.24 (1H, d, J = 16.2 Hz, 4-CH2), 2.30 (1H, d,
J = 16.2 Hz, 4-CH2), 2.46 (1H, d, J = 16.6 Hz, 2-CH2),
2.57 (1H, d, J = 16.6 Hz, 2-CH2), 3.39–3.48 (1H, m,
CH3CHH), 3.59–3.68 (1H, m, CH3CHH), 4.86 (1H, q,
J = 6.4 Hz, 6-H), 7.16–7.25 (2H, m, 9,10-H), 7.69 (1H,
dd, J = 8.7 Hz, 1.9 Hz, 11-H), 8.13 (1H, dd, J = 8.7 Hz,
1.9 Hz, 8-H) ppm; 13C NMR (100 MHz, CDCl3):
d = 15.32, 20.14, 27.67, 29.65, 31.81, 41.05, 44.99,
50.45, 55.99, 107.44, 122.02, 123.80, 123.87, 126.65,
126.87, 128.50, 136.54, 139.55, 157.51, 190.50 ppm; MS
(EI, 70 eV): m/z = 325 (M?), 310 (M?-CH3).
This compound was obtained from salt 2c in 52% yield as
1
yellowish crystals. M.p.: 204–206 °C. According to its H
NMR spectrum, this product is a mixture of two stereo-
1
isomers in 2:1 ratio (accordingly, two sets of H NMR
shifts are given in parentheses; the first set is for the major
isomer). 1H NMR (500 MHz, DMSO-d6): d = 1.25 (3H, d,
J = 6.0 Hz, 3-CH3), 1.56 (3H, d, J = 6.0 Hz, 1-CH3),
3.21–3.74 (2H, m, CH2), [(4.28–4.44, m) and (4.07–4.20,
m), 1H, 3-CH], [(5.23–5.39, m) and (5.00–5.14, m), 1H,
1-CH], [(7.37, d, J = 8.5 Hz) and (7.32, d, J = 8.5 Hz),
1H, 8-H], 7.41–7.66 (5H, m, Ph), [(7.77, s) and (7.68, s),
1H, 5-H], [(7.90, d, J = 8.5 Hz) and (7.85, d, J = 8.5 Hz),
1H, 7-H], 14.45 (1H, br s, N?-H) ppm; 13C NMR
(125 MHz, DMSO-d6): d = 18.05, 23.18, 24.90, 29.47,
38.45, 120.93, 121.14, 123.70, 124.29, 124.40, 125.02,
127.00, 129.77, 130.01, 136.53, 136.73, 138.99 ppm; MS
(EI, 70 eV): m/z = 327 (M?), 312 (M?-CH3).
3,4,5,6-Tetrahydro-3,3,6-trimethyl-5-(phenyl-
methyl)[1]benzothieno[2,3-c]quinolin-1(2H)-one
(11d, C25H25NOS)
This compound was obtained from salt 4d in 63% yield as
white crystals. M.p.: 171–173 °C; 1H NMR (400 MHz,
CDCl3): d = 1.04 (3H, s, 3-CH3), 1.12 (3H, s, 3-CH3), 1.40
(3H, d, J = 6.4 Hz, 6-CH3), 2.29 (2H, s, 4-CH2), 2.47 (1H,
d, J = 16.9 Hz, 2-CH2), 2.57 (1H, d, J = 16.9 Hz, 2-CH2),
4.61 (1H, d, J = 16.8 Hz, C6H5CHH), 4.83 (1H, q,
J = 6.4 Hz, 6-H), 4.95 (1H, d, J = 16.8 Hz, C6H5CHH),
7.15 (2H, d, J = 7.6 Hz, 2,6-Ph), 7.18–7.34 (5H, m, 9,10-
H, 3,4,5-Ph), 7.70 (1H, d, J = 8.0 Hz, 11-H), 8.18 (1H, d,
J = 8.0 Hz, 8-H) ppm; 13C NMR (100 MHz, CDCl3):
d = 21.09, 28.05, 28.59, 32.84, 43.02, 51.35, 53.48, 58.71,
108.19, 114.61, 122.09, 123.85, 126.11, 126.51, 127.02,
127.89, 128.94, 129.13, 136.36, 136.62, 139.76, 157.52,
191.08 ppm; MS (EI, 70 eV): m/z = 387 (M?), 372
(M?-CH3).
1,2,3,5,6,11b-Hexahydro-5-phenyl[1]benzothieno
[3,2-g]indolizine hydrochloride (10, C20H20ClNS)
This compound was obtained from salt 8 in 81% yield as
rose crystals. M.p.: 299–301 °C; 1H NMR (400 MHz,
DMSO-d6): d = 1.88–2.29 (3H, m, 6-CHH, 2-CH2), 2.58–
2.72 (1H, m, 6-CHH), 2.89–3.07 (1H, m, 1-CHH), 3.33–
3.46 (3H, m, 1-CHH, 3-CH2), 4.67–4.83 (1H, m, 11b-CH),
5.02–5.18 (1H, m, 5-CH), 7.39–7.61 (5H, m, 3,4,5-Ph, 8,9-
H), 7.75–7.84 (1H, dd, J = 8.6 Hz, 2.5 Hz, 7-H), 7.87–
7.96 (2H, d, J = 7.1 Hz, 2,6-Ph), 7.99–8.09 (1H, dd,
J = 8.6 Hz, 2.5 Hz, 10-H), 12.74 (1H, br s, N?-H) ppm;
13C NMR (100 MHz, DMSO-d6): d = 22.00, 30.06, 30.42,
51.39, 60.87, 62.26, 121.74, 122.72, 124.73, 125.02,
127.56, 128.63, 129.06, 129.24, 131.58, 135.73, 137.00,
138.27 ppm; MS (EI, 70 eV): m/z = 305 (M?), 228
(M?-C6H5).
3,4,5,6-Tetrahydro-5-(4-methoxyphenyl)-3,3,6-tri-
methyl[1]benzothieno[2,3-c]quinolin-1(2H)-one
(11e, C25H25NO2S)
This compound was obtained from salt 4e in 69% yield as
white crystals. M.p.: 173–174 °C; 1H NMR (400 MHz,
CDCl3): d = 1.05 (3H, s, 3-CH3), 1.07 (3H, s, 3-CH3), 1.53
(3H, d, J = 6.4 Hz, 6-CH3), 2.18 (1H, d, J = 16.8 Hz,
2-CH2), 2.24–2.31 (2H, m, 4-CH2), 2.38 (1H, d,
J = 16.8 Hz, 2-CH2), 3.84 (3H, s, OCH3), 5.00 (1H, q,
J = 6.5 Hz, 6-H), 6.95 (2H, d, J = 9.0 Hz, 2,6-Ph), 7.19
(2H, d, J = 8.5 Hz, 3,5-Ph), 7.21–7.29 (2H, m, 9,10-H),
7.72 (1H, d, J = 8.0 Hz, 11-H), 8.16 (1H, d, J = 8.0 Hz,
8-H) ppm; 13C NMR (100 MHz, CDCl3): d = 20.99,
27.95, 28.65, 32.52, 43.01, 51.28, 55.86, 58.88, 109.63,
General procedure for sodium borohydride reduction
of compounds 4c–4f
To a suspension of the pyridinium salt 4c–4f (3 mmol) in
10 cm3 methanol, 20-fold excess of sodium borohydride
was added with care at room temperature, avoiding intense
evolution of hydrogen. During addition of NaBH4 the
pyridinium salt dissolved and, finally, the solution formed
was heated under reflux for 3 h. The solution was con-
centrated and diluted with a large amount of water. The
123